Clinical Trial Update: Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma [NA]

View source ↗

Summary

Clinical trial studying Yttrium-90 radioembolization for intermediate and advanced hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Yttrium-90 radioembolization (yttrium-90 microspheres)

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: Hepatocellular Carcinoma, Radioembolization | NA | Status: COMPLETED